Latest Cordis Stories
STOCKHOLM, August 31, 2010 /PRNewswire/ -- - The Publication of 10-Year Follow-Up Test Results on the First CYPHER(R) Sirolimus-Eluting Coronary Stent Patient Reveal the Stent's Outstanding Efficacy and Safety Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a...
STOCKHOLM, August 30, 2010 /PRNewswire/ -- - The Stent for Life Initiative (SFL) Celebrates its First Year Anniversary as the ESC 2010 Congress in Stockholm, Monday August 30th InspireMD Ltd., a medical device company engaged in the development and commercialization of MGuard(TM) novel stent systems, is happy to announce that it has joined the Stent for Life Initiative as a supporting organization.
DALLAS, August 17, 2010 /PRNewswire/ -- - ReportsandReports Announces it Will Carry the U.S.
PARIS, May 27, 2010 /PRNewswire/ -- - New Trial Results on ExoSeal(TM) Vascular Closure Device Support its Clinical Safety* and Efficacy Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced the launch of the ExoSeal(TM) Vascular Closure Device.
NEW BRUNSWICK, N.J., May 25 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Medical Devices & Diagnostics business for the investment community, beginning at 8:30 a.m. (Eastern Time) on Thursday, June 3rd.
PARIS, May 25, 2010 /PRNewswire/ -- - NEVO(TM), Incorporating RES TECHNOLOGY(TM), Continues to Support Excellent Safety and Efficacy Outcomes vs.
Peripheral Vascular Device Market to Almost Double by 2016 VANCOUVER, May 11 /PRNewswire-FirstCall/ - According to a new report by iData Research (www.idataresearch.net), the leading authority in medical device and pharmaceutical market research, the U.S.
WATERLOO, Belgium, April 6, 2010 /PRNewswire/ -- Cordis Corporation announced that Christian M. Spaulding, M.D., Ph.D., FESC, FACC, has been named as Worldwide Vice President of Medical Affairs.
WATERLOO, Belgium, March 17, 2010 /PRNewswire/ -- - SORT OUT III Data Presented at American College of Cardiology Meeting in Atlanta and Published in the Lancet Investigators reported the long-term follow-up of the largest randomized comparison between the CYPHER(R) Sirolimus-eluting Coronary Stent and Medtronic's Endeavor(R) Stent highlighting significant and sustained clinical differences.
WATERLOO, Belgium, March 11, 2010 /PRNewswire/ -- - PRESILLION(TM) PLUS CoCr Coronary Stent Offers New Levels of Delivery, Support and Restoration for Arteriosclerotic Arteries Cordis Corporation today announced the European launch of its next generation of bare metal stent system - PRESILLION(TM) PLUS.
- A transitional zone between two communities containing the characteristic species of each.